default author photo

Tao Jiang

Tongji University - Department of Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

186

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Camrelizumab Plus Nab-Paclitaxel and Carboplatin as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer (ES-SCLC): A Phase II Trial

Number of pages: 19 Posted: 05 Feb 2024
Jia Yu, Anwen Xiong, Lei Wang, Xinlong Zheng, Tao Jiang, Qi Wang, Bin Chen, Menghang Yang, Wei Li, Jiajia Yuan, Changhong Zhao, Xiaohui Chen, Caicun Zhou and Shengxiang Ren
Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Fujian Medical University - Fujian Medical University Cancer Hospital, Tongji University - Department of Oncology, Tongji University - Shanghai Pulmonary Hospital, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Fujian Medical University - Department of Thoracic Surgery, Tongji University - Department of Medical Oncology and Tongji University - Department of Medical Oncology
Downloads 86 (765,566)

Abstract:

Loading...

Camrelizumab, Nab-paclitaxel, Immunotherapy, ES-SCLC

2.

Development and Validation of a Pathomic Biomarker for Immunotherapy Response via Confounder-Aware Representation Learning

Number of pages: 24 Posted: 11 Jan 2022
Jiajun Deng, Jiancheng Yang, Likun Hou, Junqi Wu, Yi He, Mengmeng Zhao, Bingbing Ni, Donglai Wei, Hanspeter Pfister, Caicun Zhou, Tao Jiang, Yunlang She, Chunyan Wu and Chang Chen
Tongji University, Tongji University, Tongji University - Tissue Bank, Tongji University, Dianei Technology, Tongji University, Shanghai Eye Hospital - Department of Ophthalmology, Harvard University, Harvard University - School of Engineering and Applied Sciences, Tongji University - Department of Medical Oncology, Tongji University - Department of Oncology, Tongji University, Tongji University and Tongji University - Department of Thoracic Surgery
Downloads 84 (777,583)

Abstract:

Loading...

Immunotherapy Biomarkers, Lung Cancer, Whole-slide Imaging, Deep Learning, Tumor Mutational Burden

3.

Consolidative Ablation Plus Third-Generation EGFR-TKIs Improves Survival in Advanced NSCLC Patients With Oligo-Residual Disease

Number of pages: 42 Posted: 03 Jun 2026
Jizhong Yin, Xinlong Zheng, Junhong Guo, Qiyu Fang, Shen Chen, Shuo Yang, Aiwu Li, Guanghui Gao, Jia Yu, Menghang Yang, Tao Jiang, Sha Zhao, Xiaozhen Liu, Lingyun Ye, Chenlei Cai, Zhengcao Xing, Xinyu Liu, Jiayi Zhu, Yan Zhang, Xiaoxia Chen, Fengyin Wu, Lei Wang, Bin Chen and Shengxiang Ren
Government of the People's Republic of China - Shanghai Changzheng Hospital, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology and Tongji University - Department of Medical Oncology
Downloads 16 (1,590,289)

Abstract:

Loading...

Non-small cell lung cancer (NSCLC), EGFR-Tyrosine kinase inhibitors (TKIs), Oligo-residual disease (ORD), Consolidative ablation